News & Updates

Psychosocial risks may impair child’s development

24 Apr 2024 by

Adverse childhood experiences (ACEs), financial needs, and other maternal psychosocial hardships can negatively affect the development of children from vulnerable families in Singapore, according to a study.

Psychosocial risks may impair child’s development

24 Apr 2024

People with depression gain most CV benefits from physical activity

22 Apr 2024

Individuals who engage in physical activities (PA) enjoy a reduced risk of cardiovascular disease (CVD), especially those suffering from depression, with a recent study showing that PA acts through the brain’s stress-related activity.

People with depression gain most CV benefits from physical activity

22 Apr 2024

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024 by

Gestational diabetes mellitus (GDM) is not associated with attention-deficit/hyperactivity disorder (ADHD) in offspring, a 20-year multinational study has shown.

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

14 Apr 2024 by

Patients with atrial fibrillation (AF) who take oral anticoagulants (OACs) and selective serotonin reuptake inhibitors (SSRIs) at the same time appear to have a higher likelihood of major bleeding.

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

14 Apr 2024

Psilocybin for depression, anxiety holds manageable safety profile

13 Apr 2024

In the treatment of individuals with depression and anxiety, therapeutic single-dose psilocybin appears to be tolerable, with acute adverse effects that are resolved within 48 hours, according to the results of a meta-analyses.

Psilocybin for depression, anxiety holds manageable safety profile

13 Apr 2024

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

11 Apr 2024 by

Excessive daytime sleepiness (EDS) is a risk factor for behavioural and emotional issues in children with obstructive sleep apnoea (OSA), researchers from the Chinese University of Hong Kong (CUHK) have shown.

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

11 Apr 2024

Study identifies 24-hour warning signs for suicide attempts among teens

09 Apr 2024

Changes in emotion, cognition, and behaviour over a 24-hour period may tell risk of suicide attempts among adolescents, with suicidal communications and withdrawal from social and other activities identified as key warning signs, according to a study.

Study identifies 24-hour warning signs for suicide attempts among teens

09 Apr 2024

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

New drug applications approved by US FDA as of 16-31 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

Prenatal topiramate not associated with autism in offspring

02 Apr 2024 by

Prenatal exposure to topiramate does not increase the risk of autism in offspring, a US nationwide cohort study has shown.

Prenatal topiramate not associated with autism in offspring

02 Apr 2024

In its 20th year, Torrent Pharma – in partnership with the Philippine Urological Association – launched Torfil (tadalafil) for the treatment of erectile dysfunction on February 13, 2024, at Hilton Hotel, Manila.

21 Mar 2024

Over 150 million men suffer from erectile dysfunction (ED) worldwide.^1,2 Despite its growing incidence, it remains underdiagnosed, with millions of men never seeking medical attention because of the sensitivity of the issue.²

In its 20th year, Torrent Pharma – in partnership with the Philippine Urological Association – launched Torfil (tadalafil) for the treatment of erectile dysfunction on February 13, 2024, at Hilton Hotel, Manila.

21 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Psychosocial risks may impair child’s development

Psychosocial risks may impair child’s development

People with depression gain most CV benefits from physical activity

People with depression gain most CV benefits from physical activity

20-year study challenges link between gestational diabetes and ADHD

20-year study challenges link between gestational diabetes and ADHD

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients

Psilocybin for depression, anxiety holds manageable safety profile

Psilocybin for depression, anxiety holds manageable safety profile

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

Daytime sleepiness: A hidden cause of behavioural and emotional issues in OSA children

Study identifies 24-hour warning signs for suicide attempts among teens

Study identifies 24-hour warning signs for suicide attempts among teens

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Prenatal topiramate not associated with autism in offspring

Prenatal topiramate not associated with autism in offspring

In its 20th year, Torrent Pharma – in partnership with the Philippine Urological Association – launched Torfil (tadalafil) for the treatment of erectile dysfunction on February 13, 2024, at Hilton Hotel, Manila.

In its 20th year, Torrent Pharma – in partnership with the Philippine Urological Association – launched Torfil (tadalafil) for the treatment of erectile dysfunction on February 13, 2024, at Hilton Hotel, Manila.